Suzanne Schubbert

Company: Xencor

Job title: Associate Director - Discovery Biology & Pharmacology

Seminars:

LAG3-Targeted IL15/IL15Rα-Fc (LAG3 x IL15) Fusion Protein for Preferential TIL Expansion 1:00 pm

Engineering LAG3 x IL15 bispecific Fc fusions for optimal activity to LAG3+ TIL with minimal peripheral activity Demonstrating potent activity and high selectivity for LAG3+ cell populations in multiple in vitro and in vivo models Showing a promising profile of selective delivery to LAG3+ cells and may preferentially expand LAG3+ TIL in patients with cancer,…Read more

day: Focus Day Track B - PM